FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Upcoming CDRH eMDR Enhancements

FDA lists three planned 2024 enhancements to the CDRH electronic medical device reporting system.

latest-news-card-1
Medical Devices

Medline Recalls Sub-G Endotracheal Tube

Medline Industries recalls its Sub-G Endotracheal Tube with Subglottic Suction due to detachment or tearing of the inflation tube.

latest-news-card-1
Human Drugs

Concerns With Alzheimers Drug Development Guidance

Biogen and Public Citizen call on FDA to address issues in its draft guidance on developing drugs to treat early Alzheimers disease.

latest-news-card-1
Medical Devices

Women Underrepresented in Device Trials: Research

Israeli researchers say more effort must be made to increase the number of women enrolled in medical device clinical trials.

latest-news-card-1
Human Drugs

Ipsen Gains Accelerated OK for Iqirvo

FDA grants Ipsen accelerated approval for Iqirvo (elafibranor) 80 mg tablets for treating primary biliary cholangitis in combination with ursodeoxycho...

latest-news-card-1
Federal Register

Obstetrics/Reproductive Advisory Panel Renewed

Federal Register notice: FDA announces the renewal of its Obstetrics, Reproductive and Urologic Drugs Advisory Committee for an additional two years.

latest-news-card-1
Federal Register

Arthritis Advisory Panel Renewed for 2 Years

Federal Register notice: FDA announces the renewal of its Arthritis Advisory Committee for an additional two years.

latest-news-card-1
Human Drugs

Emerging Drug Safety Technology Meeting Program

FDA launches an Emerging Drug Safety Technology Meeting (EDSTM) program to assist industry in implementing artificial intelligence activities related ...

latest-news-card-1
Biologics

GSKs Arexvy Gets Expanded Approval

FDA approves an expanded use for GSKs Arexvy (respiratory syncytial virus vaccine, adjuvanted) for preventing RSV lower respiratory tract disease.

latest-news-card-1
Medical Devices

FDA Clears 2 Abbott OTC Glucose Monitors

FDA clears two Abbott 510(k)s for over-the-counter continuous glucose monitoring systems Lingo and Libre Rio.